appear
spread
novel
sever
acut
respiratori
syndrom
coronaviru
led
offici
declar
global
pandem
state
us
implement
shelterinplac
order
unpreced
scale
robust
persontoperson
transmiss
rate
asymptomat
period
two
week
lead
widespread
infect
overwhelm
healthcar
infrastructur
around
globe
effect
public
health
measur
requir
extens
accur
rapid
test
determin
infect
rate
describ
strategi
use
establish
clialicens
clinic
laboratori
perform
valid
laboratorydevelop
test
ldt
berkeley
california
surround
bay
area
commun
procedur
implement
technic
regulatori
data
manag
workstream
necessari
clinic
sampl
process
provid
roadmap
aid
other
set
similar
test
center
note
nomenclatur
accord
establish
virolog
infecti
diseas
nomenclatur
throughout
document
use
refer
viral
agent
caus
infect
refer
human
infecti
diseas
caus
viral
agent
introduct
laboratori
licens
laboratori
space
begin
test
patient
sampl
process
compris
partner
uc
berkeley
health
servic
center
certifi
clinic
laboratori
notifi
center
medicar
medicaid
servic
intent
extend
clia
certif
select
fdaapprov
commerci
test
platform
basi
establish
ldt
valid
result
ldt
accord
clia
guidelin
achiev
formid
task
igi
team
divid
special
subteam
respons
establish
execut
parallel
necessari
procedur
technic
suppli
chain
regulatori
human
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
resourc
data
manag
sampl
collect
sampl
report
process
necessari
laboratori
oper
initi
effort
march
process
first
patient
sampl
use
ldt
three
week
later
april
thu
dedic
structur
threeweek
effort
team
develop
valid
operation
ldt
describ
cliacompli
manner
enabl
pcrbase
test
report
result
patient
sampl
collabor
clinic
partner
provid
comprehens
descript
igi
diagnost
test
laboratori
document
strategi
address
relev
regulatori
infrastructur
requir
allow
us
enabl
commun
test
berkeley
area
igiuc
berkeley
uh
diagnost
test
laboratori
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
test
categor
waiv
moder
complex
high
complex
base
test
score
across
seven
categori
consid
clia
test
categor
see
use
link
clia
test
categor
qpcrbase
test
consid
high
complex
highcomplex
test
clia
certifi
laboratori
must
hold
special
certif
ensur
abil
perform
complex
test
certif
complianc
survey
cm
certif
accredit
survey
privat
accredit
organ
typic
clia
certif
clinic
laboratori
must
appli
receiv
state
licens
feder
clia
certif
usual
lengthi
process
emerg
pandem
situat
temporarili
relax
regulatori
requir
expedit
review
cm
california
depart
public
health
made
possibl
extend
exist
clia
certif
state
licens
highcomplex
test
licens
clss
laboratori
meet
requir
governor
newsom
execut
order
particip
effort
critic
complianc
perspect
invalu
scientif
develop
workflow
chief
thoma
state
march
letter
laboratori
director
respons
compet
assess
document
personnel
test
laboratori
director
must
provid
list
test
personnel
along
document
compet
upon
request
lf
therefor
develop
document
train
strategi
uc
berkeley
scientist
volunt
guidanc
tang
center
cl
staff
submit
evid
cdph
lf
prior
train
educ
relev
field
submit
cv
either
transcript
diploma
letter
phd
thesi
advisor
attest
relev
individu
possess
advanc
degre
specif
educ
requir
relax
emerg
public
health
crisi
clia
regul
still
requir
test
personnel
rigor
train
evalu
initi
period
ensur
qualiti
perform
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
ensur
safeti
staff
viru
patient
sampl
inactiv
time
sampl
collect
see
sampl
collect
method
mean
infecti
viru
never
present
test
facil
precaut
laboratori
oper
condit
provid
higher
standard
safeti
condit
typic
employ
inactiv
especi
stringent
ppe
requir
establish
includ
dispos
outer
layer
mask
fit
staff
member
addit
precaut
level
biosafeti
ppe
result
determin
maxim
protect
health
volunt
staff
see
personnel
biosafeti
hipaa
train
section
sampl
collect
kit
return
test
facil
health
partner
contain
patientidentifi
inform
thu
hipaa
complianc
observ
laboratori
procedur
personnel
ensur
hipaa
complianc
laboratori
space
access
physic
visual
anyon
train
personnel
laboratori
window
close
blind
ensur
visibl
insid
lab
possibl
photographi
video
permit
laboratori
space
addit
patient
health
inform
share
outsid
hipaacompli
commun
method
therefor
laboratori
inform
manag
system
lim
built
ensur
hipaa
complianc
semimanu
autom
approach
test
workflow
see
laboratorydevelop
section
data
gener
instrument
laboratori
isol
extern
network
instrument
data
transmit
lim
use
secur
protocol
addit
instrument
data
period
purg
laboratori
instrument
store
encrypt
storag
server
harden
secur
locat
moreov
person
enter
lab
must
complet
hipaa
train
see
personnel
biosafeti
hipaa
train
test
laboratori
staff
member
train
best
practic
relat
accord
bua
hipaa
ppe
well
gener
laboratori
procedur
safeti
prior
start
laboratori
test
work
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
hipaa
train
provid
thomson
reuter
hipaa
privaci
secur
california
cours
cover
fundament
hipaa
privaci
secur
principl
administr
physic
technic
safeguard
handl
use
protect
health
inform
addit
chapter
cours
cover
medic
privaci
law
california
includ
requir
concern
handl
use
protect
health
inform
penalti
violat
california
state
law
personnel
involv
accept
access
test
result
patient
sampl
requir
take
class
pass
exit
examin
begin
work
facil
nontest
staff
present
laboratori
patient
health
inform
exist
must
also
hipaatrain
eg
equip
technician
supplementari
file
personnel
train
complianc
provid
detail
laboratori
biosafeti
procedur
well
full
train
checklist
requir
laboratori
staff
member
commenc
work
minim
risk
infecti
individu
enter
build
diagnost
laboratori
hous
hour
prior
entri
personnel
complet
selfscreen
questionnair
see
supplementari
file
personnel
train
complianc
daili
self
assess
questionnair
enter
move
within
test
facil
individu
includ
equip
technician
supervisor
must
wear
appropri
ppe
time
enter
test
facil
personnel
must
put
ppe
follow
order
lab
coat
dispos
isol
gown
tie
back
doubl
glove
inner
glove
cuff
respir
face
shield
addit
ankl
must
expos
personnel
must
wear
close
shoe
prefer
specif
pair
worn
test
laboratori
dispos
ppe
item
gown
glove
leav
test
facil
unless
enclos
biohazard
bag
spray
extern
ethanol
respir
must
rigor
fit
staff
member
fit
perform
uc
berkeley
eh
expert
verifi
air
flow
seal
ensur
protect
user
detail
ppe
requir
personnel
see
supplementari
file
personnel
train
complianc
sever
commerciallyavail
diagnost
test
detect
viral
rna
use
revers
transcript
combin
polymeras
chain
reaction
rtpcr
receiv
eua
fda
igi
chose
test
develop
market
thermo
fisher
scientif
fig
b
due
avail
test
reagent
compat
equip
robust
test
perform
hand
pilot
experi
howev
enact
modif
eua
workflow
implement
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
thermo
fisher
test
becam
laboratorydevelop
test
ldt
defin
cm
fda
therefor
establish
analyt
clinic
valid
adapt
test
experi
determin
limit
detect
bridg
assay
compar
result
author
test
site
decis
make
modif
thermo
fisher
workstream
root
desir
increas
test
throughput
reduc
cost
ensur
safeti
volunt
make
use
exist
donat
equip
increas
throughput
implement
multipl
autom
liquid
handler
use
qpcr
machin
increas
capac
reduc
cost
protect
suppli
chain
pressur
test
valid
use
thermo
fisher
rna
extract
qpcr
protocol
half
suggest
reaction
volum
discuss
reduc
reaction
volum
ensur
safeti
volunt
substitut
standard
patient
sampl
univers
transport
medium
utm
virusinactiv
buffer
discuss
sampl
collect
section
modif
thermo
fisher
protocol
ldt
develop
valid
within
clia
framework
notic
valid
submit
fda
bridg
studi
origin
eua
award
thermo
fisher
within
day
window
specifi
law
due
complex
establish
fulli
autom
workflow
interest
support
commun
test
effort
earliest
possibl
time
design
workflow
support
two
parallel
workstream
semimanu
approach
autom
approach
initi
patient
test
semimanu
approach
capac
testsday
final
implement
autom
approach
capac
testsday
see
tabl
equip
use
differ
two
approach
see
supplementari
figur
semimanu
approach
workflow
autom
workflow
integr
instrument
manag
patient
sampl
data
implement
laboratori
inform
manag
system
lim
custom
process
oper
need
igi
test
facil
use
third
wave
analyt
lockbox
lim
personnel
third
wave
analyt
custom
lockbox
lim
base
need
semimanu
autom
approach
costeffect
hipaacompli
way
intent
implement
system
two
main
phase
phase
one
build
correspond
semimanu
approach
establish
core
laboratori
oper
system
manag
deidentifi
barcod
sampl
data
oper
data
test
occur
includ
highli
autom
sampl
record
creation
test
data
manag
data
autoanalysi
final
output
lockbox
lim
analyz
sampl
result
await
approv
final
report
appropri
laboratori
personnel
phase
one
ensur
hipaa
complianc
semimanu
lim
phi
enter
lim
deidentifi
patient
barcod
use
sampl
track
upon
report
health
partner
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
uh
tang
center
lim
return
comma
separ
valu
csv
file
includ
deidentifi
barcod
result
sent
tang
center
integr
electron
health
system
patient
result
connect
specif
patient
file
via
barcod
match
phase
two
lim
build
correspond
fulli
autom
approach
implement
hipaacompli
portal
test
request
report
enabl
test
nonuc
berkeley
patient
sampl
given
largescal
capac
fulli
autom
ldt
oper
testsday
third
wave
analyt
partner
institut
look
establish
clinic
test
knowledg
gain
partnership
leverag
rapidli
develop
implement
appropri
lim
similar
custom
setup
detail
lim
interfac
workflow
pleas
see
supplementari
figur
supplementari
video
semimanu
lim
interfac
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
figur
overview
innov
genom
institut
test
consortium
igi
consortium
assay
discuss
report
overview
thermo
fisher
taqpath
multiplex
diagnost
solut
show
step
author
eua
black
igi
manual
implement
workflow
magenta
igi
test
lab
establish
two
phase
phase
start
autom
array
patient
sampl
follow
manual
implement
thermo
fisher
kit
phase
fulli
autom
workflow
b
genom
ncbi
ref
translat
region
diagram
rectangl
gene
target
thermo
fisher
kit
shown
teal
open
read
frame
gene
product
shown
grey
open
read
frame
target
thermo
fisher
kit
encod
nonstructur
protein
replic
spike
nucleocapsid
n
gene
encod
two
structur
protein
figur
creat
use
biorendercom
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
standard
sampl
collect
kit
use
copan
similar
tube
univers
transport
medium
utm
nasopharyng
np
oropharyng
op
swab
np
swab
prefer
higher
viral
load
collect
sampl
though
type
accept
per
cdc
guidelin
due
bottleneck
suppli
np
swab
standard
copan
tube
current
use
op
swab
sampl
collect
kit
well
shorter
copantyp
tube
adapt
setup
custom
insert
fit
hamilton
microlab
starlet
tube
rack
see
supplementari
fig
tabl
critic
equip
reagent
igi
semimanu
workflow
step
rna
extract
assembl
qpcr
reaction
run
qpcr
reaction
differ
autom
workflow
describ
note
column
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
igi
work
develop
relationship
multipl
health
care
provid
partnership
requir
develop
workflow
work
parti
instanc
sinc
develop
ldt
tang
center
licens
work
close
togeth
tang
center
clinician
clinic
laboratori
establish
specimen
collect
process
occur
student
popul
separ
citi
berkeley
public
health
depart
establish
partnership
lifelong
medic
care
requisit
test
collect
specimen
first
respond
eg
firefight
homeless
igi
partner
lifelong
receiv
sampl
individu
well
one
challeng
design
sampl
collect
kit
clinician
protocol
group
specimen
arriv
igi
differ
sourc
access
test
togeth
integr
cliagrad
best
practic
step
test
pipelin
addit
challeng
respons
igi
ensur
result
accur
requir
build
redund
pipelin
check
multipl
step
batch
collect
kit
assembl
need
qualitycontrol
igi
see
kit
design
eas
use
easili
tang
center
lifelong
clinician
nurs
tang
center
lifelong
differ
electron
medic
record
emr
manag
system
differ
mechan
connect
patient
record
barcod
compat
robot
access
step
kit
differ
whether
igi
provid
barcod
whether
barcod
gener
within
healthcar
system
tang
center
lifelong
respons
requisit
test
patient
collect
specimen
integr
sampl
emr
follow
transport
igi
acquisit
personnel
perform
multipl
check
confirm
barcod
patient
identifi
present
match
tube
within
kit
requisit
manifest
sampl
match
reject
specimen
recollect
verifi
barcod
lim
track
specimen
progress
test
pipelin
return
result
result
need
rematch
patient
record
test
complet
report
lower
overal
cost
assay
per
test
limit
reagent
use
face
suppli
chain
shortag
sought
reduc
quantiti
reagent
use
per
rna
extract
rtqpcr
assay
pilot
experi
demonstr
test
perform
robustli
reduct
proceed
valid
workflow
halfreact
size
see
supplementari
file
semimanu
sop
exact
volum
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
follow
section
report
assay
valid
data
conduct
reduc
volum
protocol
compris
valid
report
cdph
basi
fda
eua
submiss
valid
ldt
requir
measur
specif
fdacdcdefin
metric
meet
exceed
benchmark
case
ldt
metric
measur
assay
limit
detect
march
fda
guidanc
recommend
identifi
lod
molecular
diagnost
conduct
dilut
seri
rna
inactiv
viru
artifici
real
clinic
matrix
fda
recommend
laboratori
test
dilut
seri
three
replic
per
concentr
confirm
final
concentr
replic
purpos
eua
fda
defin
limit
detect
lowest
concentr
replic
posit
section
describ
experiment
data
establish
lod
ldt
experiment
determin
limit
detect
perform
serial
dilut
posit
control
rna
see
method
triplic
x
x
copiesml
copiesml
step
dilut
determin
ct
cycl
threshold
three
gene
ngene
sgene
well
spikedin
bacteriophag
nucleic
acid
intern
control
nucleic
acid
extract
effici
qpcr
amplif
ct
valu
invers
proport
amount
start
target
rna
repres
pcr
cycl
number
fluoresc
signal
reaction
cross
set
threshold
threshold
set
manual
base
background
fluoresc
reaction
mixtur
across
six
dilut
test
observ
mean
ct
valu
littl
variabl
among
sampl
indic
consist
nucleic
acid
rna
extract
fig
lowest
concentr
test
x
copiesml
abl
detect
amplif
three
primerprob
set
replic
sampl
despit
consist
detect
indic
x
copiesml
detect
limit
fig
left
x
observ
amplif
three
target
gene
howev
valu
reproduc
across
triplic
fig
undetect
singl
replic
x
copiesml
thu
limit
detect
identifi
x
copiesml
lowest
concentr
test
target
gene
detect
replic
extract
pcr
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
next
sought
confirm
measur
x
genom
copiesml
lod
perform
assay
technic
replic
replic
detect
three
gene
well
intern
control
demonstr
consist
posit
ct
valu
fig
left
control
nonspecif
amplif
extract
human
rna
cell
subject
rna
extract
rtqpcr
workflow
observ
cross
reactiv
four
primerprob
set
fig
full
workflow
control
nucleic
acid
extract
pcr
control
show
expect
valu
detect
amplif
gene
nucleic
acid
water
sampl
fig
pcr
control
posit
control
thermo
fisher
exhibit
expect
amplif
three
gene
target
well
expect
absenc
nucleic
acid
togeth
result
show
abl
detect
replic
exceed
requir
defin
fda
establish
x
genom
copiesml
lod
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
concentr
limit
detect
highest
ct
valu
fig
sampl
n
gene
defin
upper
ct
boundari
reliabl
call
posit
sampl
set
report
criteria
ct
return
neg
neg
result
defin
analysi
softwar
gene
sampl
three
genom
target
assay
return
posit
diagnosi
eua
thermo
fisher
taqpath
combo
kit
dictat
two
three
gene
target
must
return
posit
rtqpcr
result
setup
translat
detect
ct
valu
less
greater
zero
two
three
gene
success
amplif
genom
target
result
reduc
amplif
effici
competit
pcr
master
mix
reagent
possibl
highli
amplifi
sampl
present
low
undetect
control
thu
decis
criteria
allow
neg
intern
control
two
three
genom
target
test
posit
abl
return
neg
result
intern
control
must
posit
addit
criteria
list
tabl
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
first
phase
test
use
manual
procedur
rna
extract
qrtpcr
setup
manual
pipet
control
creat
duplic
pcr
plate
rna
extract
plate
tabl
add
outcom
decis
matrix
use
manual
protocol
sampl
result
inconclus
shall
retest
one
time
ensur
diagnost
test
clinic
valid
fda
recommend
laboratori
confirm
perform
assay
seri
contriv
clinic
specimen
test
minimum
contriv
reactiv
specimen
nonreact
specimen
reactiv
specimen
creat
spike
dilut
rang
chosen
span
lod
establish
fig
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
addit
neg
sampl
creat
dilut
human
rna
purifi
tissu
cultur
cell
plate
includ
known
posit
neg
sampl
taken
leftov
sampl
process
local
clinic
test
facil
sampl
provid
us
sampl
collect
medium
use
facil
univers
transport
medium
dilut
dnarna
shield
prepar
sampl
workflow
dilut
sampl
collect
medium
perform
rna
extract
see
method
figur
show
result
first
clinic
valid
test
design
workflow
rna
extract
two
replic
rtqpcr
plate
gener
run
parallel
plate
must
return
concord
result
pass
criteria
interpret
posit
neg
result
result
one
plate
shown
figur
second
plate
result
supplementari
materi
supplementari
fig
meet
clinic
valid
criterion
rna
virusspik
sampl
must
posit
unspik
sampl
must
neg
shown
figur
ldt
attain
requir
sensit
specif
valid
assay
workflow
test
addit
known
posit
known
neg
sampl
differ
test
facil
sampl
gener
gift
jeffrey
shapiro
kaiser
permanent
origin
assay
kaiser
permanent
clia
laboratori
use
roch
kit
target
e
gene
fig
roch
test
system
provid
us
deidentifi
bear
phi
specimen
test
facil
creat
kaiser
sampl
transfer
sampl
utm
new
tube
equal
volum
dnarna
shield
pb
sampl
collect
buffer
facil
campu
inactiv
decontamin
releas
lab
sampl
run
workflow
igi
fig
supplementari
fig
clinic
sampl
return
result
concord
result
report
kaiser
permanent
tabl
ct
valu
known
posit
specimen
span
wide
rang
provid
good
coverag
dynam
rang
clinic
valid
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
tabl
concord
igi
assay
result
extern
result
detect
kaiser
permanent
leftov
clinic
sampl
posit
neg
run
igi
detect
assay
result
decis
matrix
see
tabl
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
previous
test
verifi
lockbox
lim
softwar
use
templat
lim
signific
custom
implement
lim
packag
per
laboratori
user
requir
detect
workflow
see
method
subsect
lim
custom
overview
custom
prior
clinic
sampl
test
custom
lockbox
lim
verifi
third
wave
analyt
personnel
ensur
custom
function
appropri
per
uniqu
user
requir
detect
workflow
end
requir
document
third
wave
analyt
intern
softwar
verif
system
first
detail
user
requir
system
function
end
laboratori
user
secondli
user
requir
list
function
requir
lim
specif
custom
meet
user
requir
test
case
creat
run
specif
function
requir
document
specif
function
requir
met
upon
verif
custom
lockbox
lim
softwar
third
wave
analyt
end
user
laboratori
perform
addit
user
accept
test
verifi
softwar
perform
anticip
fulli
autom
assay
establish
valid
time
public
updat
manuscript
includ
autom
method
workflow
implement
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
provid
descript
path
establish
igi
diagnost
test
laboratori
develop
valid
diagnost
test
rtqpcrbase
test
show
reproduc
limit
detect
x
viral
genom
copiesml
compar
favor
valid
test
current
use
commun
test
encount
sever
bottleneck
convert
academ
research
laboratori
clinic
diagnost
test
facil
share
experi
help
other
process
first
foremost
laboratori
must
ensur
meet
regulatori
requir
infrastructur
staff
includ
clia
certif
hipaa
complianc
fda
author
experi
extend
licens
exist
clia
certifi
licens
facil
use
onlin
hipaa
train
adapt
commerci
avail
fda
certifi
test
use
equip
save
time
resourc
addit
manag
suppli
chain
bottleneck
use
donat
equip
reduc
testsampl
volum
use
assay
adopt
inhous
sampl
barcod
adapt
materi
sampl
tube
work
avail
equip
identifi
local
sourc
ppe
post
call
mask
glove
gown
websit
succeed
locat
suffici
suppli
personnel
use
plan
week
oper
lab
support
personnel
assign
work
shift
success
plan
place
ensur
uninterrupt
oper
experi
patient
sampl
collect
ratelimit
step
sampl
analysi
pipelin
continu
address
challeng
interfac
health
center
patient
sampl
intak
soon
implement
web
portal
purpos
describ
futur
updat
manuscript
invest
cover
initi
cost
equip
suppli
cost
analysi
indic
pertest
rate
per
test
reagent
consum
includ
personnel
cost
continu
investig
mechan
reimburs
includ
local
state
feder
govern
sourc
facil
also
benefit
philanthrop
donat
cover
cost
test
uninsur
patient
repetit
asymptomat
patient
test
pandem
continu
intent
provid
pcrbase
diagnost
test
advanc
research
asymptomat
transmiss
analyz
viru
sequenc
evolut
provid
benchmark
new
diagnost
technolog
resourc
permit
intend
conduct
routin
surveil
test
enabl
rapid
identif
infect
individu
enabl
restrict
viru
spread
way
academ
test
center
like
limit
viral
transmiss
local
enabl
economi
restart
nation
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
method
fdaapprov
diagnost
test
infect
primarili
base
quantit
realtim
polymeras
chain
reaction
rtqpcr
measur
viral
rna
present
within
patient
specimen
intact
specimen
collect
nasopharyng
oropharyng
swab
health
care
facil
submit
diagnost
test
facil
rna
extract
sampl
rtqpcr
use
detect
viral
sgene
ngene
along
rna
technic
control
test
score
posit
neg
viral
infect
base
valid
limit
detect
ct
threshold
use
eua
approv
criteria
identifi
thermo
fisher
instruct
tabl
serial
dilut
posit
control
rna
thermofish
taqpath
control
kit
prepar
sampl
collect
medium
dnarna
shield
dilut
phosphatebuff
salin
pb
span
x
x
genom
copi
rna
per
ml
rtqpcr
reaction
run
use
triplic
concentr
threshold
valu
set
manual
base
background
fluoresc
reaction
mixtur
bacteriophag
genom
rna
thermo
fisher
use
intern
control
rna
extract
revers
transcript
pcr
amplif
perform
replic
target
lod
confirm
limit
detect
establish
fulli
autom
method
start
test
patient
sampl
semimanu
method
lower
scale
detail
standard
oper
procedur
semimanu
approach
found
supplementari
file
semimanu
sop
addit
visual
guid
import
detail
step
found
supplementari
figur
notabl
step
laboratori
test
eg
step
start
complet
time
directli
track
laboratori
technician
use
tablet
comput
directli
report
lim
sampl
collect
kit
prepar
separ
laboratori
test
facil
kit
compos
oropharyng
swab
short
copanlik
tube
order
improv
medic
prefil
igi
sampl
collect
medium
steril
dnarna
shield
pb
ziptop
biohazard
bag
lot
number
prepar
preload
tube
sampl
collect
medium
record
bag
tang
center
patient
intak
produc
barcod
affix
sampl
collect
tube
intak
paperwork
sampl
return
igi
secondari
contain
ambient
temperatur
detail
kit
assembl
patient
sampl
collect
transport
tang
center
found
supplementari
file
kit
prepar
patient
sampl
collect
transport
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
briefli
sampl
acquisit
kit
receiv
patient
sampl
tube
biohazard
bag
contain
match
barcod
patient
identifi
inform
kit
examin
determin
accept
reject
test
reject
criteria
includ
fulli
partial
uncap
sampl
tube
absenc
swab
compromis
sampl
identif
illeg
tube
identif
match
biohazard
bag
observ
contamin
collect
medium
visibl
liquid
kit
biohazard
bag
reject
sampl
kit
dispos
made
biohazard
wast
recollect
respect
patient
investig
pursu
health
partner
possibl
accept
patient
sampl
tube
spray
molecular
biologygrad
ethanol
wipe
kimwip
biosafeti
cabinet
store
plug
test
workflow
test
workflow
consist
four
main
step
access
rna
extract
rtqpcr
result
clean
barcod
patient
sampl
tube
place
hamilton
microlab
starlet
rack
scan
array
barcod
plate
either
store
transfer
directli
extract
personnel
rna
extract
phase
pleas
see
supplementari
file
hamilton
microlab
starlet
autom
process
detail
starlet
process
bespok
starlet
autom
code
starlet
output
csv
file
upload
lim
regist
deidentifi
sampl
databas
receiv
pend
extract
extract
personnel
place
centrifug
seal
deepwel
plate
pcr
clean
hood
rna
extract
hood
reagent
prepar
thermo
fisher
eua
magmax
viralpathogen
nucleic
acid
isol
kit
use
reduc
reaction
volum
approach
see
valid
method
section
sampl
process
digest
proteinas
k
addit
nucleic
acidbind
magnet
bead
pipett
tip
switch
sampl
throughout
process
avoid
crosscontamin
rtqpcr
taqpath
rtpcr
kit
thermo
fisher
posit
control
rna
x
genom
copiesml
use
neg
control
molecular
biolog
grade
water
thermo
fisher
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
equival
rtqpcr
personnel
thaw
preload
master
mix
plate
light
min
replic
rtqpcr
plate
prepar
match
sampl
posit
identif
rtqpcr
plate
use
manual
enter
lim
interfac
rtqpcr
step
manual
check
complet
pcr
held
appli
biosystem
fast
thermalcycl
thermo
fisher
reaction
output
plate
manual
upload
lim
system
analysi
upload
output
analyz
synthes
lim
neg
posit
result
evalu
cl
lim
new
specimen
request
sampl
result
neg
posit
test
result
two
full
test
possibl
report
result
includ
posit
neg
new
specimen
request
sampl
result
discord
sampl
replic
plate
result
invalid
inconclus
sampl
requeu
lim
full
retest
start
access
phase
tabl
upon
valid
result
review
cl
result
need
report
relev
physician
well
state
local
author
result
workflow
follow
call
physician
requisit
test
critic
posit
result
return
posit
neg
inconclus
specimen
insuffici
result
pdf
report
per
patient
physician
test
result
offici
report
posit
neg
inconclus
result
transmit
csv
hipaacompli
manner
use
uc
berkeley
googl
email
servic
addit
virtru
encrypt
cdph
upload
california
report
diseas
inform
exchang
calredi
typic
report
local
health
author
must
done
within
one
hour
report
posit
result
clinician
format
specifi
public
health
author
report
cdph
must
done
within
hour
via
electron
transmiss
howev
public
health
order
bay
area
jurisdict
serv
clinic
lab
call
report
test
result
posit
order
local
public
health
author
specifi
electron
transmiss
result
calredi
system
fulfil
report
requir
obviat
need
report
directli
bay
area
local
health
author
test
cdph
use
calredi
report
statelevel
statist
cdc
phase
two
lim
implement
physician
access
portal
provid
result
pdf
format
requisit
physician
integr
provid
electron
medic
record
system
like
epic
return
cdph
report
calredi
via
interfac
instead
csv
lockbox
lim
softwar
use
templat
lim
oem
instal
softwar
packag
run
salesforc
platform
signific
custom
implement
meet
laboratori
user
requir
detect
workflow
custom
includ
autom
sampl
record
creation
upon
upload
sampl
barcod
display
custom
sampl
process
instruct
laboratori
user
sampl
test
eg
sampl
test
sop
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
autom
record
updat
throughout
sampl
test
process
eg
autom
updat
sampl
test
plate
status
creation
userfriendli
data
import
tool
eg
upload
raw
ct
data
upon
complet
rtqpcr
autom
analysi
control
sampl
data
gener
final
patient
result
instantan
upon
raw
data
upload
custom
userfriendli
workflow
final
review
sampl
data
appropri
laboratori
personnel
export
result
data
import
health
partner
system
eg
uh
tang
center
autom
sampl
record
creation
upon
retest
sampl
track
reagent
control
lot
test
custom
dashboard
track
sampl
throughout
test
process
creation
provid
portal
form
partner
commun
order
report
result
nonuc
berkeley
patient
implement
robust
secur
measur
ensur
phi
encrypt
rest
appropri
personnel
access
appropri
record
data
field
descript
statist
patient
sampl
use
manuscript
come
deidentifi
dataset
accord
human
subject
protect
approv
uc
berkeley
committe
protect
human
subject
cph
institut
review
board
irb
approv
requir
research
use
human
subject
clinic
laboratori
activ
exclus
support
cliacertifi
clinic
oper
activ
govern
cm
hipaa
legisl
order
publish
data
manuscript
result
develop
test
workstream
sought
irb
approv
uc
berkeley
cph
uc
berkeley
committe
protect
human
subject
determin
analys
present
manuscript
qualifi
human
subject
research
data
set
deidentifi
analyz
result
irb
submiss
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
reach
us
berkeleyedu
question
comment
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
